New COVID‑19 Vaccine: What about Cost and Utility?

Sora Yasri, Viroj Wiwanitkit


Dear Editor,

Coronavirus disease 2019 (COVID‑19) already causes health problems in more than 50,000,000 people around the world. The effective way to prevention of this emerging coronavirus disease is vaccination.[1] Recently (November 2020), many pharmaceutical manufacturers declared for success in COVID‑19 vaccine developments. There are also reports on efficacy of the vaccine and proposed price of the vaccination. As a new vaccination, the important consideration is on vaccine affordability and accessibility.


COVID‑19; Vaccine, Costs; Utility

Full Text:



Corey L, Mascola JR, Fauci AS, Collins FS. A strategic approach

to COVID‑19 vaccine R&D. Science 2020;368:948‑50.

Karim SA. COVID‑19 vaccine affordability and accessibility.

Lancet 2020;396:238.

Yasri S, Wiwanitkit V. Cost‑effectiveness of varicella vaccination.

Int J Prev Med2019;10:120.